Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART
Holding IART?
Track your performance easily

Integra Lifesciences (IART) Cash flow

234 Followers

Integra Lifesciences Cash Flow

IART's free cash flow for Q3 2024 was $-7.16M. For the 2024 fiscal year, IART's free cash flow was decreased by $-160.18M and operating cash flow was $22.48M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 105.41M$ 139.96M$ 264.47M$ 312.43M$ 203.83M$ 231.43M
Investing Cash Flow
$ -394.26M$ -94.18M$ -58.58M$ -161.44M$ -68.07M$ -162.67M
Financing Cash Flow
$ 195.35M$ -229.93M$ -251.95M$ -98.23M$ 121.63M$ -8.77M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 1.30B$ 276.40M$ 456.66M$ 513.45M$ 470.17M$ 198.91M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
------
Issuance Of Debt
$ 378.81M$ 46.62M$ -107.80M$ -100.25M$ 281.15M$ -9.20M
Repayment Of Debt
$ -203.99M$ -118.48M$ -148.55M$ -125.75M$ -465.35M$ -246.10M
Free Cash Flow
$ 17.52M$ 73.09M$ 233.27M$ 264.41M$ 168.60M$ 161.93M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Integra Lifesciences Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis